1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dearling, JL; Dunning, P; Fahey, F; Huston, JS; Meares, CF; Packard, AB; Smith, SV; Snay, E; Treves, ST; Voss, SD | 1 |
Cutler, C; Figueroa, SD; Gallazzi, F; Lacy, JL; Lu, BY; Quinn, TP; Vazquez-Flores, GJ; Yue, Z; Yuen, J; Zhang, X | 1 |
Craig, AS; Harrison, A; Matthews, RC; Parker, D; Pereira, KA; Royle, L; Walker, CA | 1 |
3 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Melanoma
Article | Year |
---|---|
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody.
Topics: Aniline Compounds; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Copper Radioisotopes; Cross-Linking Reagents; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Melanoma; Mice; Positron-Emission Tomography | 2011 |
Copper-62 labeled ReCCMSH peptide analogs for melanoma PET imaging.
Topics: Animals; Copper Radioisotopes; Female; Half-Life; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Inhibitory Concentration 50; Melanoma; Mice; Mice, Inbred C57BL; Peptide Fragments; Positron-Emission Tomography; Receptor, Melanocortin, Type 1 | 2012 |
67Ga-9N3 uptake by xenografts of human melanotic melanoma in mice.
Topics: Animals; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Tissue Distribution; Transplantation, Heterologous | 1992 |